Buchang USA Company Profile

03:41 EDT 20th September 2017 | BioPortfolio

News Articles [3 Associated News Articles listed on BioPortfolio]

M&As this week: Lonza Group, Shandong Buchang Pharmaceutical

Swiss biopharmaceutical company Lonza Group has completed the acquisition of HansaBioMed Life Sciences OU, an Estonian pharmaceutical company.

Deals this week: Shanghai Fosun Pharmaceutical Group, Shandong Buchang Pharmaceutical, 4SC

Shanghai Fosun Pharmaceutical Group intends to raise approximately HK$2.32bn ($298.3m) through a private placement of 80.6 million shares.

Beijing's Symbow Closes $17 Million Funding for Surgical Navigator

Symbow Medical completed a $17 million Series A funding, led by China healthcare fund Huayi Capital. Symbow, a Beijing company, is developing a surgical navigation device that is designed to be used t...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "Buchang USA" on BioPortfolio

We have published hundreds of Buchang USA news stories on BioPortfolio along with dozens of Buchang USA Clinical Trials and PubMed Articles about Buchang USA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Buchang USA Companies in our database. You can also find out about relevant Buchang USA Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record